Medically reviewed by Dr Sin Yong · Last reviewed · 14 min read · Doctor-performed, never delegated · Jump to questions
Related: collagen biostimulators in Singapore, Sculptra vs Ellansé vs HA filler.
See also: Ellansé in Singapore.
Dr Sin Yong · MBBS (NUS) · MRCS (Edin) · MSc Aesthetic Medicine with Distinction (Queen Mary, London) · MSc Practical Dermatology (Cardiff) · Global Key Opinion Leader
Sculptra is injectable poly-L-lactic acid. It adds no lasting volume of its own; it is a scaffold the skin builds collagen around over months, and it cannot be dissolved. It is assessed and placed by Dr Sin Yong on Orchard Road, Singapore.
Sculptra is injectable poly-L-lactic acid, a collagen biostimulator rather than a filler. It adds little volume on the day; the change builds gradually as the skin lays down new collagen. In Singapore its cost depends on the assessment, how much product is planned and how treatment is staged, and it cannot be dissolved once placed.
Sculptra is poly-L-lactic acid (PLLA), a biodegradable synthetic polymer manufactured by Galderma and used in dissolvable sutures and orthopaedic implants for decades. For aesthetic use it is supplied as a sterile powder of microparticles, reconstituted with sterile water before injection and placed in the deeper layers of the skin or just beneath them. It received US FDA approval in 2004 for HIV-associated facial lipoatrophy and in 2009 for nasolabial fold contour deficiencies.
It is not a filler in the ordinary sense. A hyaluronic acid filler is a gel that occupies space the moment it is placed. Poly-L-lactic acid occupies very little space of its own. Fibroblasts treat the particles as a scaffold and lay down new type I collagen around them gradually, while the particles slowly break down by hydrolysis. What remains is your own collagen, not resident product. That distinction decides the timing of the result, the areas it suits, and what can be done if it goes wrong.
“"Sculptra only tightens." It doesn't. Collagen is tissue. It takes up space.”
Dr Sin YongOn what collagen stimulators actually do
The fullness visible straight after treatment is almost entirely the water it was mixed with, plus the swelling that follows any injection. Both settle, and the face often looks much as it did before. This is normal, and it is the point at which people who were not warned decide the treatment has failed. The real change is slower: collagen is produced gradually, so the product cannot be judged on the day, and it is the wrong choice for anyone who needs a change before a near event. Because the response continues after the appointment, placing enough on the day to see a result is the commonest route to too much later, and too much cannot be taken back.

If a lump forms after treatment, the guide to hard filler lumps explains how it is assessed.
It suits diffuse, structural volume loss: the overall deflation of the mid-face, temples and lower face that comes with age or after significant weight loss, in a patient who can wait for a gradual result and understands it cannot be reversed. It is particularly logical where the face reads tired rather than lined. Thin faces, full faces, age and the under-eye exclusion are covered under am I suitable for a biostimulator.
| Group | Typical situation | What usually happens |
|---|---|---|
| Tends to suit | Diffuse deflation of the mid-face, temples and lower face; a face that reads tired rather than lined; able to wait and attend review | Staged, conservative placement with reassessment |
| Should not have it | Known hypersensitivity to any component; a history of, or tendency to, keloid or hypertrophic scarring (both contraindications in the US FDA labelling) | Not used |
| Better to wait | Pregnancy or breastfeeding; active infection or inflammation in the area, including an acne flare or a cold sore | Deferred |
| Assessed first | Immune suppression or an active autoimmune condition; a bleeding tendency or blood-thinning medicines; earlier non-dissolvable or unknown filler in the area | Discussed carefully; earlier filler scanned first, which may rule it out |
| Poor candidates by expectation | A visible change needed before a near event; unable to return for review; uneasy with a result that cannot be reversed | Another option, or no treatment |
| Referred on | A jowl or loose jawline from laxity; lumps or heaviness from earlier filler | Focused ultrasound or VF Lift – Vertical Facelift assessment; ultrasound scan and filler correction |
Sculptra is a collagen biostimulator, not a filler: it is placed as a dilute suspension and the body builds collagen around the particles over the following months. Because it cannot be dissolved and keeps building after the appointment, it goes only where the tissue is thick enough to hide a particle and where a gradual, diffuse change is wanted. The published consensus favours a more dilute suspension and deeper placement, on or near the bone, where the skin is thin, and allows a less dilute product in the deeper subcutaneous plane of the fuller cheek.
| Area | Placed here? | Dilution and plane, in words | What is checked at review |
|---|---|---|---|
| Temples | Yes, for diffuse hollowing | More dilute, placed deep over the bone, because temple skin is thin and the vessels run close | Whether the hollow has softened evenly; any firmness along the hairline |
| Cheeks (mid-face) | Yes, for broad deflation in a face with good skin thickness | Deep subcutaneous plane across the cheek, spread rather than pooled | Symmetry, whether the collagen response has started, and whether a second placement is needed at all |
| Jawline and pre-jowl area | Yes, for deflation beside the chin; not for a sagging jowl | Deep placement in the pre-jowl hollow only; the jowl itself is a laxity problem | Whether the hollow has filled without adding heaviness to the jowl |
| Hands | Discussed at assessment | Dilute, beneath the skin and above the tendons, planned separately from the face | Any firmness over the tendons; evenness between the hands |
| Chin | No, for shaping | Projection calls for a product with form on the day, usually on bone support | Not applicable |
| Under-eye, lips and fine lines | No | Thin, mobile skin shows every particle, and a nodule there cannot be dissolved; a reversible hyaluronic acid product is used instead | Not applicable |
| Material | What it is | How it works | Can it be dissolved? | Where it is typically considered |
|---|---|---|---|---|
| PLLA (poly-L-lactic acid) | Microparticles reconstituted in sterile water | Prompts the body's own collagen gradually; little immediate volume | No | Diffuse volume loss in the temples, cheeks and jawline, placed in stages |
| CaHA (calcium hydroxylapatite) | Microspheres in a gel carrier | The gel gives immediate support; collagen forms around the spheres; also used diluted for skin quality | No | Support on bone, such as the jawline, chin and nose |
| PCL (polycaprolactone) | Microspheres in a gel carrier | Immediate correction from the gel, with collagen stimulation around the spheres | No | Contour and support on bone |
| Hyaluronic acid (HA) | Cross-linked gel | Fills and binds water to add volume straight away | Yes, with hyaluronidase | Areas where reversibility matters, such as the lips and under-eye |
Which material suits you is an anatomical decision made at assessment, not a preference. The options are compared in more depth on collagen biostimulators in Singapore and collagen injection vs collagen biostimulator. For a single discrete temple hollow, hyaluronic acid is used at this practice because it can be dissolved.
Hyaluronidase, the enzyme used to reverse hyaluronic acid filler, has no action on poly-L-lactic acid. If it is placed too superficially, in the wrong plane or in excess, the options are time, targeted treatment of any nodules, and in some cases procedural removal. None of those is equivalent to dissolving.
Collagen is tissue and takes up space, so it builds gradual volume rather than tightening.
Hyaluronidase acts on hyaluronic acid only, so poly-L-lactic acid cannot be dissolved and is planned conservatively.
The common findings are those of any deep injectable: swelling, bruising, tenderness and temporary asymmetry while the water settles. Papules and nodules are the specific risk of this product: the US pivotal trial reported them in 17.2% of patients, typically appearing months after treatment and mostly resolving on their own. Dilution, depth of placement and post-treatment massage all influence that figure, which is why technique rather than brand is the variable that matters. The serious risks are the vascular ones that attend any product placed near facial vessels, which is why plane and anatomy matter more than the product.
Any lump that is growing, painful or red is examined rather than massaged on faith; the lumps and nodules after poly-L-lactic acid page covers what is done. For migrated poly-L-lactic acid and other non-HA product, Dr Sin Yong uses the Sculpting mode of Time Freeze Laser LCLR®, which takes away the excess, after mapping with ultrasound; see nodules vs migration and filler correction.
Previous filler is mapped with ultrasound first. Dilution and plane are then set region by region, the product is placed, and the treated areas are massaged as instructed. The day in sequence, including the massage rules, is set out under what to expect at a biostimulator visit.
The sequence below describes phases, not a timetable: how quickly each passes depends on the area and the person, and is discussed at consultation.
Recovery is described in full under downtime after poly-L-lactic acid, and the do and do-not list is on the aftercare page.
The cost of Sculptra in Singapore depends on how much product your face needs and how that is staged, which can only be judged at assessment. There is no fixed number of vials for a face, and a figure quoted before an examination would describe a plan that does not yet exist. The extent of the volume loss matters most: diffuse deflation across the temples, mid-face and lower face needs more than a single area. Face size, skin thickness and the dilution chosen for each region also change how much is used, and earlier filler may need to be scanned and sometimes dissolved first.
Staging is the other variable. Because poly-L-lactic acid keeps building collagen after the appointment and cannot be dissolved, Dr Sin Yong under-corrects deliberately and decides any further placement at review. The number of vials is therefore an outcome of the plan rather than something chosen in advance. Prices are discussed at consultation rather than published, in line with Singapore's rules on medical advertising. What sets the fee, vial by vial, is on cost factors, and how quotes work is on how we quote.
Poly-L-lactic acid is a planning product more than an injecting product. The decisions that determine the result are made before the needle: how much water the powder is reconstituted with, which plane each region is placed in, and how much is placed at a first visit against how much is left for reassessment. Dr Sin Yong plans dilution and plane region by region, because the temple, the mid-face and the pre-jowl area are different depths and different tissues. He under-corrects deliberately, reviews as the collagen response develops, and decides any further placement from what the skin has actually produced rather than from a pre-sold plan.
A face that has been injected more than once often arrives with a complaint that sounds like it needs more product: a heaviness in the lower face, a fullness under the eyes, a lump months after the last visit. In Dr Sin Yong's experience the problem is more often what is already there, and the answer is subtraction, not addition. So before any further placement, he scans. High-frequency ultrasound shows what material is in the tissue, how deep it is, whether it has migrated, and whether a lump is poly-L-lactic acid, old hyaluronic acid filler, a cyst or scar. If the scan shows that less is what you need, that is filler correction, a different procedure. If it shows a clean field, placement can go ahead. Nothing is added to a face that has not been looked beneath.
Question not answered here? Ask on WhatsApp, use the enquiry form, or browse 100 questions patients ask.
Medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last updated 23 October 2026 · Editorial policy
Whether a non-dissolvable biostimulator is the right answer depends on the anatomy, on what has been injected before, and on how much time you have. Dr Sin Yong assesses that first.
Arrange a consultation